Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2

Published:2022-09-22 Issue:18 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Chaisawangwong Worarat^ORCID,Wang Hanzhi,Kouo Theodore,Salathe Sebastian F.,Isser Ariel^ORCID,Bieler Joan Glick^ORCID,Zhang Maya L.,Livingston Natalie K.^ORCID,Li Shuyi,Horowitz Joseph J.,Samet Ron E.^ORCID,Zyskind Israel^ORCID,Rosenberg Avi Z.^ORCID,Schneck Jonathan P.^ORCID

Funder

National Institutes of Health Grants

National Science Foundation Graduate Research Fellowships

National Research Service Award (NRSA) fellowships

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/158308/files/pdf

Reference44 articles.

1. Johns Hopkins. Coronavirus Resource Center. https://coronavirus.jhu.edu/ Accessed August 12, 2022

2. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis

3. Characteristics of SARS-CoV-2 and COVID-19

4. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

5. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza Vaccination Mediates SARS-CoV-2 Spike Protein Peptide-Induced Inflammatory Response via Modification of Histone Acetylation;Vaccines;2024-07-01

2. Immunogenicity and protective efficacy of an influenza virus-like particle-based SARS-CoV-2 hybrid vaccine candidate in rhesus macaques;2024-05-24

3. The Influence of Cross-Reactive T Cells in COVID-19;Biomedicines;2024-03-02

4. Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population;Cell Reports;2024-01

5. In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms;Cellular & Molecular Immunology;2023-12-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3